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Self-Reactive B Lymphocytes Overexpressing Bcl-xL
Escape Negative Selection and Are Tolerized
by Clonal Anergy and Receptor Editing
transgenic (Tg) mouse models. The B cells of Ig Tg mice
bearing receptors that recognize the self-antigens MHC
class I, red blood cells, or native double stranded DNA
are deleted in the bone marrow (BM) (Nemazee and
Burki, 1989; Okamoto et al., 1992; Chen et al., 1995), or
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selection and tolerance in the B lineage (Goodnow,Australian National University
1996). In this model, Tg B cells bearing an Ig receptorCanberra ACT 2601
specific for hen egg lysozyme (HEL) reversibly arrest inAustralia
development and then die within 1 day in BM when they
encounter membrane-bound HEL expressed as a self-
antigen (mHEL) (Hartley et al., 1991; Hartley et al., 1993).
Summary
When HEL-Ig Tg mice are crossed with mice expressing
a secreted form of the self-antigen (sHEL), self-reactive
Self-reactive B cells Tg for both a bcl-xL death inhibi- B cells do not receive sufficient cross-linking of their
tory gene and an Ig receptor recognizing hen egg lyso- antigen (Ag) receptors to undergo clonal deletion, but
zyme (HEL-Ig) efficiently escaped developmental ar- instead become unresponsive to Ag (Goodnow et al.,
rest and deletion in mice expressing membrane-bound 1988; Cooke et al., 1994).
self-antigen (mHEL). In response to the same antigen, Clonal deletion of immature B lymphocytes in BM
Tg HEL-Ig B cells not expressing bcl-xL were deleted, occurs by apoptosis. In the WEHI 231 cell line model
while cells expressing bcl-2 were arrested at the im- for negative selection, either of the apoptosis inhibitory
mature B stage. Bcl-xL Tg B cells escaping negative genes bcl-2 (Tsujimoto et al., 1984; Bakhshi et al., 1985;
selection were anergic in both in vitro and in vivo Cleary and Sklar, 1985) or bcl-xL (Boise et al., 1993) can
assays and showed some evidence for receptor edit- block IgM receptor±induced death of cells (Kamesaki
ing. These studies suggest that Bcl-x may have a dis- et al., 1994; Choi et al., 1995; Fang et al., 1995; Merino
tinct role in controlling survival at the immature stage et al., 1995). In the HEL Tg system, a bcl-2 transgene
of B cell development and demonstrate that tolerance was found to delay deletion of mHEL-reactive immature
is preserved when self-reactive B cells escape central B cells, although it did not prevent developmental arrest
(Hartley et al., 1993). Of interest, the expression of bcl-2deletion.
and bcl-xL is differentially regulated during normal B cell
development in BM (Fang et al., 1994; Merino et al.,Introduction
1994; Fang et al., 1996; Grillot et al., 1996). The highest
levels of Bcl-xL expression are found at the pre-B cellDuring lymphoid development, DNA rearrangements of
stage (B2201, cytoplasmic m1, surface IgM2), with inter-the immunoglobulin (Ig) and T cell receptor genes result
mediate levels in pro-B and immature B cells and lowin the generation of lymphocytes bearing an extensive
levels in mature B cells. Bcl-2 is expressed in nearly aarray of antigen receptor specificities (Tonegawa, 1983;
reciprocal pattern with high levels in mature B cells andAlt et al., 1987; Davis and Bjorkman, 1988). Although
low levels in pre-B and immature B cells. Importantly, Bthis process is necessary to provide the diverse immune
cells with a gene-targeted deletion of bcl-x have severelyrepertoire required to recognize a broad array of foreign
impaired development beyond the pro-B stage (Ma etantigens, one consequence of random V(D)J recombina-
al., 1995; Motoyama et al., 1995), suggesting that Bcl-xLtion is that immune cells bearingreceptors able to recog-
expression (likely at the pre-B cell stage) is crucial fornizeendogenous self-antigens are generated. In order to
B cell development.
prevent overt autoimmune disease, these autoreactive
We recently generated B cell±restricted bcl-xL Tg micecells must be disposed of or tolerized.
to explore further the role of bcl-xL in B lymphocyteIn the Blineage, clonaldeletion isan important mecha- development (Fang et al., 1996). These animals develop
nism to eliminate self-reactive B cells early in their de- a large expansion of B2201CD431 pro-B cells in BM
velopment (Nossal, 1994; Rajewsky, 1996). Certain VH that contain out-of-frame or otherwise nonproductive
families are underrepresented in the peripheral B cell heavy chain Ig rearrangements, which in normal animals
compartment of both mouse and human (Huetz et al., are rapidly deleted by apoptosis in BM. bcl-xL Tg pro-B
1993; Decker et al., 1995; ten Boekel et al., 1997), in part cells also have a significant survival advantage in vitro,
because some VH genes encode self-reactive specifici- with cells maintaining viability in the absence of growth
ties. The importance of clonal deletion in shaping the B factors for several weeks. Based on the expression pat-
cell immune repertoire is supported by a number of Ig tern of Bcl-xL, the severe defect in B cell development
in cells lacking bcl-x, and the ability of this gene to
regulate negative selection in a model cell line,we exam-§To whom correspondence should be addressed (e-mail: behre001
@maroon.tc.umn.edu). ined the influence of the bcl-xL transgene in the HEL Tg
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Figure 1. A Rearranged Ig Transgene Elimi-
nates the Pro-B Cell Expansion in bcl-xL B
Cell Tg Mice
BM from C57Bl/6J control (B6), HEL-Ig Tg, B
cell bcl-xL Tg, and HEL-Ig/bcl-xL double Tg
mice was stained with Cychrome-conjugated
anti-B220 MAbs and FITC-conjugated anti-
CD43 MAbs and analyzed by two-color flow
cytometry. Data shown is from the lymphoid
gate, and numbers refer to the percent of total
BM cells. Pro-B cells are B220loCD431 (lower
gate), whilepre-B and surface Ig positivecells
are B220intermediate or hiCD43neg (upper gate).
model system for negative selection. These experiments HEL-binding B cells in BM (Figures 2D, 2H, and 2L) and
in the periphery, including the spleen (Figures 2P, 2T,demonstrate the efficient ability of bcl-xL to disrupt both
developmental arrest and deletion in the B lineage, in 2X), blood, and lymph nodes (data not shown). The es-
cape of double Tg cells in these mice was impressive,contrast tooverexpression of bcl-2, suggesting differen-
tial roles of these two molecules in B cell development. with the mHEL recipients of HEL-Ig/bcl-xL BM having
similar overall numbers of B cells in BM and spleen asFurthermore, these data indicate that clonal anergy and
Ig receptor editing of self-reactive cells that escape de- found in controlchimeras lackingself-Ag (Table 1). Thus,
the bcl-xL transgene allowed self-reactive B cells thatletion are important mechanisms to prevent autoim-
mune B cell responses. normally arrest in development and die in the BM to
escape clonal deletion.
By surface staining, the density of surface IgMa andResults
IgDa was reduced in many of the double Tg cells escap-
ing negative selection compared to controls, with levelsA bcl-xL Transgene Allows Mature Self-Reactive
B Cells To Escape Negative Selection of IgMa appearing more affected than IgDa (Figure 2).
The levels of HEL binding were also reduced in manyB cell±restricted bcl-xL Tg mice have an expanded pro-
B cell (B2201, CD431) population enriched for cells with of these cells compared to controls (Figure 2). As shown
in Figure 3A, the escaped cells expressed levels of thetwo failed Ig heavy chain rearrangements (Fang et al.,
1996) (Figure 1). When HEL-Ig Tg mice were bred with mature B cell markers CD21, CD23, and CD62L (Gallatin
et al., 1983; Ahearn and Fearon, 1989; Conrad, 1991)bcl-xL Tg mice, the resulting double Tg progeny no
longer exhibited the pro-B cell expansion (Figure 1). This that were comparable with those found in normal HEL-
Ig B cells. The escaped cells were also CD191, CD221,indicated that expression of a functional Ig receptor
was sufficient to drive the majority of B cell precursors ICAM-11, and B7±2neg (data not shown). Thus, bcl-xL
overexpression in autoreactive B cells not only allowedthrough the pro-B to pre-B cell developmental check-
point, similar to the accelerated B cell development ob- them to escape clonal deletion, but also helped them
overcome the developmental arrest previously reportedserved in single Tg HEL-Ig mice (Figure 1).
In order to test the hypothesis that bcl-xL would dis- in this system.
rupt negative selection in the B lineage, we prepared
radiation chimeras by infusing donor BM from HEL-Ig Escape of B Cells in Triple Tg Mice Is Similar
to that Observed in Chimerassingle Tg or HEL-Ig/bcl-xL double Tg mice into lethally
irradiated recipient C57Bl/6J (B6) control or mHEL self- To rule out the possibility that the Bcl-xL-mediated es-
cape from negative selection was an artifact of the radia-Ag-expressing mice. BM and spleens from 6±12-week-
old chimeras were analyzed for maturation in the B tion chimera system, HEL-Ig/bcl-xL Tg mice were bred
with mHEL Tg animals to produce triple Tg mice (HEL-lineage, using monoclonal antibodies to the transgene-
specific heavy chain allotype (IgMa and IgDa) and the Ig/bcl-xL/mHEL). Similar to the radiation chimeras, the
spleens of triple Tg mice also contain a population ofanti-HEL sandwich assay (Goodnow et al., 1988), to de-
tect Tg HEL-Ig or HEL-Ig/bcl-xL B cells that bound self- self-reactive B cells that escape negative selection (data
summarized in Table 1). These cells also express mark-Ag. In all experiments, the extent of hematopoetic chi-
merism was routinely monitored by staining with IgMb ers of mature B cells (CD21, CD23, CD62L) and have a
similar surface IgM and IgD profile as observed in theallotype MAbs (specific for host endogenous B cells),
and animals were excluded from analysis unless .95% HEL-Ig/bcl-xL → mHEL chimeras (data not shown). Im-
munohistochemistry showed that the escaping B cellsdonor chimerism was observed.
As previously reported (Hartley et al., 1991, 1993), in HEL-Ig/bcl-xL/mHEL triple Tg mice and HEL-Ig/
bcl-xL → mHEL chimeras homed to the B cell regionstransfer of HEL-Ig single Tg BM into mice expressing
the self-Ag mHEL resulted in arrested B cell devel- of lymphoid follicles (data not shown). Because all of
the cells in triple Tg animals express the self-Ag HEL, weopment in BM with abundant B2201IgMa(2) cells, only a
few B2201IgMa1, HEL-binding cells, and virtually no were unable to use the HEL sandwich assay to reliably
assess by flow cytometry whether the Ag receptors onIgDa1 cells detected (Figures 2B, 2F, and 2J). The
spleens of HEL-Ig → mHEL recipients also contained neg- these cells bound HEL protein. However, incubation of
these cells in vitro with soluble or plate-bound HEL ledligible numbers of Tg B cells (Figures 2N, 2R, and 2V).
In striking contrast, mHEL recipients of HEL-Ig/bcl-xL to a further down-modulation of cell surface levels of
IgMa (data not shown; see Figure 4, below), suggestingdouble Tg BM had significant numbers of IgMa1, IgDa1,
Bcl-xL Transgenic B Cells Escape Negative Selection
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Figure 2. HEL-Ig/bcl-xL Double Tg B Cells
Escape Deletion inmHEL Radiation Chimeras
Two-color flow cytometry plots of BM (A±L)
and spleen (M±X) from radiation BM chimeras
prepared by introducing BM from HEL-Ig
mice into lethally irradiated C57Bl/6 (B6) con-
trol (A, E, I, M, Q, and U) or mHEL (B, F, J, N,
R, and V) recipients, and HEL-Ig/bcl-xL BM
into B6 (C, G, K, O, S, and W) or mHEL (D, H,
L, P, T, and X) recipients. The IgMa and IgDa
MAbs are specific for the HEL-Ig Tg heavy
chain allotype. HEL-binding B cells were de-
tected using the HEL sandwich assay. The
HyHEL9 MAb used for the sandwich assay
detects only receptor-bound HEL and does
not recognize cell surface mHEL. Dual stain-
ing demonstrated that all HEL-binding cells in
the various chimeras were IgMa1. Plots were
gated on lymphoid cells, and the numbers
shown are the percent of total ungated cells.
Data is representative of at least eight inde-
pendent chimeras for each group analyzed
at 6±12 weeks of age.
that the majority of the escaped B cells in the triple Tgs bcl-xL in this system, mixed chimeras were prepared in
which BM from HEL-Ig/bcl-2 mice (bearing the CD45.1had affinity for the self-Ag HEL.
allele) and HEL-Ig/bcl-xL mice (bearing the CD45.2 allele)
were coinfused into lethally irradiated mHEL recipientsbcl-xL versus bcl-2 Transgenes
Previous experiments investigating the influence of (either CD45.1 or CD45.2 allele), and the animals were
analyzed 6±8 weeks following transplant. As previouslybcl-2 in the HEL-Ig/mHEL system had shown that a bcl-2
transgene allowed extended survival of cells undergoing described, HEL-Ig/bcl-2 Tg cells (CD45.11) were ar-
rested at the IgMlo, IgDneg,CD21lo-neg,HSAhi stage of devel-negative selection, but the cells remained arrested at
an immature stage of B cell development (IgMlo, IgDneg, opment in the BM, with an accumulation of similarly
arrested B cells in the spleen (Hartley et al., 1993) (FigureCD21lo) (Hartley et al., 1993). In contrast, the bcl-xL trans-
gene appeared to facilitate the differentiation of B cells 3B, only the CD21 staining is shown). In the same ani-
mals, the HEL-Ig/bcl-xL Tg B cells (CD45.21) demon-escaping deletion to a more mature stage (Figures 2
and 3A). To directly compare the influence of bcl-2 and strated a more mature surface phenotype characterized
Table 1. B Cell Populations in Radiation Chimera Recipients and Single, Double, and Triple Transgenics
Chimeras* Single, Double, and Triple Tgs²
HEL-Ig HEL-Ig HEL-Ig/bcl-x HEL-Ig/bcl-x HEL-Ig/ HEL-Ig/bcl-x/
→ B6 → mHEL → B6 → mHEL HEL-Ig mHEL HEL-Ig/bcl-x mHEL
Cells Cell Numbers (3 1026)
Bone Marrow
Total Cellularity 57.1 6 10.4 30.4 6 5.9 55.7 6 6.6 46.1 6 5.0 94.2 6 12.6 65.5 6 13.9 103.3 6 10.8 76.0 6 11.7
B2201IgMa(2) 1.2 6 0.4 5.1 6 1.8 0.9 6 0.4 3.2 6 1.7 2.8 6 0.5 1.9 6 0.4 3.0 6 0.2 2.6 6 0.5
B2201IgMa1 1.5 6 0.2 0.4 6 0.1 2.4 6 0.5 2.0 6 0.9 3.5 6 1.8 3.4 6 1.0 5.0 6 0.4 2.7 6 0.5
B2201HEL1 1.5 6 0.3 0.4 6 0.2 2.2 6 0.5 1.8 6 0.8
Spleen
Total Cellularity 58.9 6 6.3 23.2 6 4.7 68.1 6 7.3 35.0 6 5.3 98.0 6 8.3 51.3 6 13.8 86.3 6 2.5 75.7 6 21.6
B2201IgMa1 11.2 6 3.2 0.2 6 0.1 12.1 6 2.9 10.2 6 2.2 14.7 6 2.0 2.5 6 0.4 12.6 6 1.1 9.8 6 3.2
B2201HEL1 10.5 6 2.1 0.1 6 0.1 11.4 6 2.6 6.4 6 2.0
*Data represents mean 6 SEM for 4±9 chimeras for each group analyzed in parallel 6±8 weeks after reconstitution.
² Data presents mean 6 SEM for 3 mice in each group analyzed in parallel at 8 weeks of age.
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Figure 3. Escaped Bcl-xL Tg B Cells Express
Cell Surface Markers Characteristic of Mature
B Cells, While Bcl-2-Expressing Cells Are De-
velopmentally Arrested
(A) Single-cell suspensions of spleen from
HEL-Ig → B6 (thin line) and HEL-Ig/bcl-xL →
mHEL (thick line) were stained with Cy-
chrome-conjugated anti-B220 MAbs and
FITC-conjugated isotype control, anti-CD21,
anti-CD23, or anti-CD62L MAbs. Histograms
of B220 gated cells are shown together with
the negative control (dotted line) staining.
Data is representative of six independent ex-
periments in chimeras and triple Tgs.
(B) CD45.2 BM cells from a HEL-Ig/bcl-xL Tg
mouse and CD45.1 BM cells from a HEL-Ig/
bcl-2 Tg mouse were mixed at 1:1 (50/50 chi-
mera) and injected into CD45.2 mHEL Tg
mice. Bcl-2-expressing cells are arrested at
a CD21neg stage, while Bcl-xL-expressing cells
mature to a CD211 stage. BM cells from a
representative 50/50 chimeric mouse show
CD21 expression on gated B2201CD45.1neg
(Bcl-xL, thick line) or B2201CD45.11 (Bcl-2,
thin line) cells. Spleen cells are from a differ-
ent 50/50 chimera with identical gating. Data
shown is typical of six mHEL recipients. 50/
50 chimeras made in B6 mice not expressing
mHEL showed no maturational arrest as both
Bcl-xL- and Bcl-2-expressing cells matured
to the CD211 stage in the BM and spleen.
Similar results were obtained using CD45.1
mHEL-expressing recipients.
by the expression of intermediate levels of IgM, high while LPS responses were comparable in all groups. A
similar defect in in vitro anti-HEL-Ig Ab secretion waslevels of IgD and CD21, and intermediate levels of heat-
stable antigen. Thus, bcl-xL allowed the escape from also evident in 7 day culture supernatants in parallel
experiments (Figure 4C). The escaped cells respondednegative selection of a more mature B cell population
than observed with bcl-2. comparably to controls following other treatments that
bypassed the Ag receptor (PMA/Ionophore and CD40L/
IL-4; data not shown). Flow cytometric analysis revealedB Cells that Escape Negative Selection
Are Anergic In Vitro that both IgM cross-linking and incubation with sHEL
led to further down-modulation of cell surface IgM levelsThe majority of HEL-Ig/bcl-xL Tg cells escaping negative
selection expressed receptors that bound self-Ag as in the escaped cells (Figure 4D), indicating a capacity
of the receptors on all of the escaped cells to binddetermined by the HEL sandwich assay, but the levels
of surface IgM on many of the cells were diminished. HEL with at least modest affinity. Together these results
indicate that the escaped cells in HEL-Ig/bcl-xL → mHELThis was reminiscent of the reduced levels of IgM ob-
served on anergic HEL-Ig B cells that are chronically chimeras and triple Tgs are unresponsive or anergic to
stimuli that cross-link the Ag receptor in vitro.exposed to soluble self-Ag (Goodnow et al., 1988).
Therefore, we tested the ability of B cells escaping nega-
tive selection in the HEL-Ig/bcl-xL → mHEL chimeras to B Cells Escaping Negative Selection
Are Unresponsive In Vivosecrete anti-HEL antibody in vitro. As shown in Figure
4A, high levels of spontaneous anti-HEL-Ig secreting In the next series of experiments, an adoptive transfer
protocol was designed to test the functional status ofELISAspot positive B cells were detected in chimeric
recipients of either HEL-Ig or HEL-Ig/bcl-xL BM in the the escaped B cells in vivo (Figure 5). Escaped or control
HEL-Ig/bcl-xL B cells were cotransferred with either na-absence of self-Ag, but only background levels were
found in HEL-Ig/bcl-xL → mHEL chimeric mice despite ive or ovalbumin-primed LN T cells into sublethally irra-
diated control B6 recipients lacking self-Ag. The micelarge numbers of mature B cells in the periphery (see
Figure 2 and Table 1). were immunized at the time of transfer with a chemical
conjugate of whole ovalbumin and HEL proteins, andA series of in vitro experiments were then performed
with highly purified splenic B cells from control and HEL- anti-HEL antibody responses were measured in serum
on days 5, 10, and 15.Ig/bcl-xL → mHEL chimeras. Cells stimulated through
the Ag receptor with polyclonal anti-IgM antibodies or Control HEL-Ig/bcl-xL B cells cotransferred with oval-
bumin-primed T cells initiated a vigorous antibody re-with the specific Ag HEL demonstrated impaired prolif-
erative responses compared to HEL-Ig → wild-type or sponse following immunization, while the transfer of
control B cells with unprimed T cells resulted in onlyHEL-Ig/bcl-xL → wild-type derived B cells (Figure 4B),
Bcl-xL Transgenic B Cells Escape Negative Selection
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Figure 4. Escaped HEL-Ig/bcl-xL Tg B cells Are Anergic In Vitro
(A) ELISAspot assays were performed on splenic B cells from the indicated chimeric mice. Shown are the results of three independent
experiments (mean 6 SEM).
(B) Purified B cells (5 3 104 cells/200 ml media) from the various chimeras were cultured alone or stimulated with LPS (20 mg/ml), polyclonal
goat-anti-mouse IgM Abs (10 mg/ml), or soluble HEL (10 mg/ml) for 72 hr. Tritiated thymidine incorporation was measured for the last 16 hr
of culture. Data are presented as mean 6 SEM of triplicate wells from a representative experiment.
(C) Supernatants from 7 day cultures of B cells stimulated as described in B were assayed for anti-HEL IgMa Ab production by ELISA. Data
presented as mean 6 SEM of triplicate wells.
(D) Flow cytometry of purified B cells (5 3 105 cells/ml media) cultured for 72 hr and stimulated as described in B. Dead cells were excluded
from the analysis based on forward and side scatter. Cells were stained with PE-conjugated anti-B220 and FITC-conjugated anti-IgMa MAbs.
background levels of antibody production (Figure 5A). assay (Figures 2P versus 2T and Table 1). This sug-
gested to us the possibility of light chain receptor editingThe escaped HEL-Ig/bcl-xL B cells, cotransferred with
either unprimed or primed T cells, failed to secrete de- in this system as a mechanism to alter the specificity
of the Ag receptors of some of the cells, a processtectable anti-HEL Ab in response to immunization (Fig-
ure 5A), suggesting profound clonal anergy of the B cells characterized by high level reexpression of the recombi-
nation activating proteins RAG1 and RAG2 and newin vivo. Analysis of splenocytes 17 days postimmuniza-
tion showed significant numbers of HEL-Ig secreting B endogenous light chain rearrangements (Gay et al.,
1993; Tiegs et al., 1993; Hertz and Nemazee, 1997).cells in the control HEL-Ig/bcl-xL plus primed T cell group
as determined by ELISAspot assay, but only back- RNA and genomic DNA were isolated from the unfrac-
tionated BM and spleens of control, HEL-Ig Tg, HEL-Ig/ground numbers in mice receiving the escaped cells
(Figure 5B). bcl-xL double Tg, HEL-Ig/mHEL double Tg, and HEL-
Ig/bcl-xL/mHEL triple Tg mice, as well as mHEL or B6
chimeric recipients of HEL-Ig/bcl-xL BM. By RT±PCR,Evidence for Receptor Editing in Cells
Rag1 and Rag2 mRNA transcripts were undetectable inEscaping Negative Selection
HEL-Ig mice (Figure 6A, lane 4), consistent with tightIn the HEL-Ig/bcl-xL → mHEL chimeras, we noted that
allelic exclusion. In this experiment, HEL-Ig/mHEL dou-a variable number (average 38%, range 26%±65%) of
ble Tg mice also failed to express detectable Rag1 butthe escaped IgMa1 B splenocytes did not bind HEL with
high affinity as determined by the HEL binding sandwich did express Rag2 (Figure 6A, lane 6), while in other
Immunity
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Figure 5. Escaped Double Tg B cells are An-
ergic In Vivo
B cells (1.1 3 106 per animal) from standard
B6 or mHEL radiation chimera recipients of
HEL-Ig/bcl-xL BM were adoptively transferred
into a second group of B6 recipients together
with naive or ovalbumin-primed lymph node
T cells (1 3 107 per animal). Three animals
were studied in each group.
(A) Serum anti-HEL IgMa titers on days 0, 5,
10, and 15 following immunization of the re-
cipient mice with HEL-ovalbumin whole pro-
tein conjugates in complete Freund's ad-
juvant.
(B) Anti-HEL ELISAspots were enumerated in
the spleens of the immunized animals at
day 17.
experiments low levels of Rag1 were detectable in a consistent finding, and there was no significant in-
crease in IgMb staining in HEL-Ig/bcl-xL → mHEL chime-HEL-Ig/mHEL BM (data not shown). Interestingly, eas-
ras or triple Tg mice compared to controls (data notily detectable levels of both Rag1 and Rag2 mRNA
shown). Thus, these results suggest that a subpopula-were detected in triple Tg (Figure 6A, lane 7) and HEL-
tion of the escaped cells have undergone endogenousIg/bcl-xL → mHEL chimeric (Figure 6A, lane 9) BM.
light chain rearrangements at the kappa locus, whichGenomic DNA from the BM and spleen of these ani-
cannot be distinguished from the Tg kappa chain bymals was then amplified with primers specific for V-Jk1
flow cytometry.rearrangements. The HEL-Ig light chain transgene is the
product of a V-Jk2 rearrangement (Smith-Gill et al.,
1987), so V-Jk1 rearrangements, if detected, would be Discussion
evidence of novel endogenous kappa rearrangements.
Indeed, V-Jk1 rearrangements were found only in triple These data demonstrate that a B cell±restricted bcl-xL
Tg mice (Figure 6B, lane 7) and in the HEL-Ig/bcl-xL → transgene is capable of blocking clonal deletion of self-
mHEL chimeras (Figure 6B, lane 9). Higher levels of the reactive B cells in the HEL-Ig/mHEL Tg model system
novel kappa locus rearrangements were detected in and suggest two mechanisms by which tolerance is
spleen than in BM of these animals (Figure 6B, compare maintained in this system: peripheral clonal anergy and
middle with top panel), consistent with an accumulation Ig light chain receptor editing.
of cells bearing endogenous rearrangements in the pe- Previous studies examining the influence of the re-
riphery. A low level of Rag1 and intermediate levels of lated apoptosis regulatory gene bcl-2 on negative se-
Rag2 were also detected in HEL-Ig/bcl-xL double Tg and lection in HEL mice showed that a bcl-2 transgene
HEL-Ig/bcl-xL chimeric mice (Figure 6A, lanes 5 and 8); prolonged the survival of immature B cells in HEL-Ig/
however, corresponding V-Jk1 rearrangements could bcl-2 → mHEL chimeras (Hartley et al., 1993); however,
not be detected (Figure 6B, lanes 5 and 8). PCR amplifi- the B cells escaping to the periphery in these mice re-
cations of genomic DNA for rearrangements at the en- mained arrested at a very early stage in development
dogenous heavy chain locus showed constitutive low unless removed from mHEL Ag and did not express cell
level DH-JH rearrangements in the BM and spleen of surface markers normally found on mature B lympho-
each of the mice, while VH-DJH rearrangements were not cytes. Data with the bcl-2 transgene support the hypoth-
observed in HEL-Ig mice but were found at very low esis that following strong cross-linking of the Ig recep-
frequency in the other animals (data not shown). tor, self-reactive B cells first arrest in development at
We also tested whether peripheral B cells of HEL-Ig/ the IgM1IgDneg CD21neg stage and then undergo apopto-
bcl-xL → mHEL chimeras or triple Tg mice expressed sis in BM.
lambda light chains and/or IgMb endogenous heavy The mixed chimera experiments described in Figure
chains by flow cytometry, as additional evidence of en- 3B directly compare the influence of bcl-2 and bcl-xL in
dogenous Ig editing. Although a few of these animals this system. bcl-xL Tg B cells escaping to the periphery
showed low levels of lambda staining slightly above the (CD21hi, IgD1) were clearly at a more mature stage in B
cell development than escaping bcl-2 Tg cells (CD21low-neg,background levels found in control mice, this was not
Bcl-xL Transgenic B Cells Escape Negative Selection
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reciprocal pattern during normal B cell development.
Bcl-xL is expressed at high levels in pre-B cells, at inter-
mediate levels in immature B cells, and at negligible
levels in mature cells (Fang et al., 1996; Grillot et al.,
1996), while Bcl-2 is expressed at very low levels in pre-B
and immature B cells and is up-regulated in mature naive
cells (Li et al., 1993; Merino et al., 1994; Fang et al.,
1996).
In preliminary experiments, we have found by intracel-
lular flow cytometric analysis that Tg Bcl-2 and Bcl-xL
proteins are robustly expressed in the respective mice
during the pre-B and immature-B developmental stages,
even though the transgenes are regulated differently in
pro-B cells (Bcl-xhi, Bcl-2lo) and in mature B cells (Bcl-xlo,
Bcl-2hi) (data not shown). Thus, the knockout pheno-
types, the normal endogenous expression patterns of
Bcl-xL and Bcl-2, and the data presented in this report
support the hypothesis that these two genes may have
distinct roles in B cell development. We have postulated
that the expression of Bcl-xL at the pre-B cell stage may
be important for regulating survival during initial light
chain rearrangement events (Fang et al., 1996; Behrens
and Mueller, 1997). Successful light chain rearrange-
ment results in IgM receptor expression and differentia-
tion to the immature stage; thus, Bcl-xL may also be
involved in control of B cell survival in the early phases
Figure 6. Evidence for Receptor Editing in HEL-Ig/bcl-xL B Cells of the immature cell stage (discussed below).
Escaping Deletion
(A) RT±PCR was performed on BM cDNA using primers specific for
Rag1, Rag2, or b-actin. Products were electrophoresed on agarose Maintenance of Tolerance in B Cells
gels and then blotted, and nitrocellulose filters were subsequently Escaping Deletionprobed with radiolabeled cDNA probes. Lane 1, H20 control; lane 2,
Many of the HEL-binding B cells that escaped negativeliver cDNA negative control; lane 3, B6 normal BM positive control;
selection and populated the periphery expressed lowerlanes 4±7, single, double, or triple Tg mice; lanes 8 and 9, radiation
chimeras. The apparent band between lanes 2 and 3 is a blotting levels of sIgM, slightly reduced levels of sIgD, butnormal
artifact. A 2 hr exposure is shown. The data shown is representative levels of various markers of mature B cells (CD19, CD21,
of three independent experiments. CD23, CD62L, and ICAM-1). This phenotype was similar
(B) Genomic DNA from BM and spleen of the same animals de-
to that observed in HEL-Ig/sHEL mice (Goodnow et al.,scribed in (A) were amplified with primers specific for V-Jk1 re-
1988) and suggested that the escaped cell populationarrangements or the Jk constant region as a control. Gels were
might be anergic. Indeed, the escaped HEL-binding Bblotted and probed with radiolabeled internal oligonucleotides. The
positive control (lane 3) is BM or spleen from a B6 mouse. A 16 cells failed to spontaneously secrete autoantibody in vitro,
hr exposure is shown. The data shown is representative of three were unresponsive to Ag receptor cross-linking in vitro,
independent experiments. and, when adoptively transferred to an environment free
of theself-Ag, could not beactivated to secrete antibody
in response to immunization. Taken together, these dataIgD2). The precise reason for the difference inphenotype
between these two closely related transgenes is un- are consistent with a state of profound anergy within
the entire escaped population, despite the disruption ofknown. It remains a formal possibility that this reflects
simply a quantitative difference in the level of transgene clonal deletion by the bcl-xL transgene.
Recent studies in other Ig Tg models and in normalexpression at the immature cell stage based on differ-
ences in the Tg expression constructs or transgene copy cells have shown that sufficiently strong cross-linking
of the IgM receptor early in the immature stage resultsnumber. However, recent observations suggest that
there may be qualitative differences in the function of in reexpression of the V(D)J recombination machinery
and new rearrangement events at endogenous Ig locithe Bcl-2 and Bcl-xL during B cell development. Perhaps
the strongest evidence is the phenotype of B cells lack- (Gay et al., 1993; Tiegs et al., 1993; Hertz and Nemazee,
1997). Editing has now additionally been documenteding either bcl-x or bcl-2 by gene-targeted deletion.
bcl-x2/2 B cells in the RAG blastocyst complementation for B cells in the periphery (Han et al., 1997; Papavasiliou
et al., 1997). In the anti-H-2Kb Ig Tg system, a bcl-2system have severely crippled development beyond the
pro-B stage (Ma et al., 1995; Motoyama et al., 1995), transgene was shown to promote editing of immature,
autoreactive B cells but could not block central deletionwhile bcl-2 knockout animals have a complex B cell
phenotype with the first wave of B cell development (Lang, et al., 1997).
We found evidence for Ig receptor editing in the HELappearing generally normal, but approximately 4±6
weeks after birth the mature immune system undergoes system following the introduction of the bcl-xL trans-
gene. Based on the initial finding that the numbers ofextensive apoptosis (Veis et al., 1993). A second point
is that Bcl-2 and Bcl-xL are expressed in essentially a B2201, IgMa1 cells were reproducibly higher than the
Immunity
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Figure 7. Bcl-xL and Bcl-2 Influence on Neg-
ative Selection of Immature B Cells
In the model shown, the binding of multivalent
autoantigen induces a reversible developmen-
tal arrest that can be overcome by a bcl-xL
transgene but not by a bcl-2 transgene. Suffi-
cient BCR cross-linking early in the immature
stage (when endogenous Bcl-xL levels are
high, or in the presence of bcl-xL transgene
expression) allows engagement of the recep-
tor editing machinery and subsequent editing
of Ig light chains resulting in cells that survive
because they no longer bind autoantigen with
high affinity. In the HEL system, bcl-xL Tg B
cells with edited light chains remain anergic
due to the affinity of the retained heavy chain
for self-antigen. In normal cells, editing might
result in either a mature B cell without self-
reactivity or an anergic cell with low level self-
reactivity.
Self-reactive cells that fail to edit their recep-
tor remain arrested in development and eventually die in the bone marrow. The death of arrested immature cells can be delayed by a bcl-2
transgene. In the setting of Bcl-xL overexpression, autoreactive cells that fail to edit do not undergo the developmental arrest, but instead
mature in an anergic state due to chronic autoantigen exposure.
numbers of B2201HEL1 cells in the periphery of mice low frequency or with low affinity for the HEL-Ig receptor,
resulting in partial activation of the recombination ma-containing escaped B cells (Figure 2 and Table 1), we
observed that RAG mRNAs were highly expressed in chinery.
BM, and novel rearrangements could be detected at
the endogenous kappa locus in HEL-Ig/bcl-xL → mHEL
Regulation of Survival of Immaturechimeras and in triple Tg mice, while HEL-Ig Tg controls
B Cells by Bcl-xLshowed no background expression of RAG or light chain
The fate of immature B cells in BM appears to dependrearrangements (Figure 6). Since reagents are not avail-
on the status of BCR cross-linking. Cells having little orable to distinguish the Tg kappa chain from newly re-
no Ag receptor occupancy are kept alive by BCR signalsarranged endogenous light chains by flow cytometry,
(Cyster et al., 1996; Torres et al., 1996) and proceedwe can not be certain whether the subpopulation of
through development, while cells with low to intermedi-cells containing endogenous rearrangements actually
ate levels of IgM cross-linking in BM are rendered aner-express the endogenous kappa chains. Similarly, we
gic (as in HEL-Ig/sHEL mice [Goodnow et al., 1988]).are unable to say whether individual escaped B cells
Immature B cells with high levels of Ag receptor occu-coexpress two chains or alternatively have deleted the
pancy transiently arrest in development and either initi-Tg light chain and express only an endogenous kappa
ate receptor editing and lose their self-reactivity or diechain. The behavior of these cells in vitro (further down-
in the BM (Figure 7). The bcl-xL and bcl-2 transgenesregulation of IgM receptor levels with antigen, and poor
differ in their ability to influence the fate of immatureproliferation to Ag receptor cross-linking) suggests that
B cells receiving strong cross-linking of the BCR byall of the escaped cells, including those with endoge-
autoantigen in this system. Bcl-2 has no effect on thenous light chain rearrangements, are anergic. In this
developmental arrest but prolongs the survival of imma-regard it is interesting that the B cells of anti-HEL heavy
ture cells that continue to bind self-Ag. In contrast, Bcl-chain Tg mice, where the Tg heavy chain is paired ran-
xL overexpression prevents cells from arresting in devel-domly with endogenous light chains, still undergo effi-
opment, supports the survival of immature cells duringcient deletion in mHEL mice, indicating that the Tg heavy
editing, and allows mature cells chronically binding self-chain alone has significant, although reduced, affinity
Ag to survive in an anergic state.for HEL (Hartley and Goodnow, 1994).
Thus, in addition to its role at the pre-B cell stage inIt was of interest that Rag2 mRNA was detected in
supporting survival during initial light chain rearrange-the BM of HEL-Ig/mHEL double Tg mice (together with
ment, we postulate that endogenous Bcl-xL may be im-low levels of Rag1 in other experiments; datanot shown),
portant in protecting immature B cells from apoptoticin the absence of evidence for endogenous kappa re-
cell death by establishing an editing ªwindowº duringarrangements. This suggested an aborted attempt in
an early phase of the immature B cell stage, within whichHEL-Ig/mHEL mice to initiate endogenous light chain
high-level Ag receptor engagement can initiate new Igrearrangements, with the cells dying in response to
rearrangements. We suggest that Bcl-xL levels fall duringstrong receptor cross-linking before they successfully
the immature stage, and the editing window may closeinitiated an editing response. Intermediate levels of
when Bcl-xL levels drop to the point where Ag receptor±Rag2 and low levels of Rag1 expression were found in
mediated death signaling can no longer be inhibited.the BM of HEL-Ig/bcl-xL mice and HEL-Ig/bcl-xL → B6
The Tg overexpression of bcl-xL extends this window ofchimeras without detectable V-Jk1 rearrangements.
opportunity for editing and, even in the face of high-levelOne possible interpretation of this finding is that endog-
enous self-Ags in normal mouse BM cross-react at a Ag receptor engagement, allows a significant fraction of
Bcl-xL Transgenic B Cells Escape Negative Selection
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1991) carrying the CD45.1 allotype were described previously (Hart-developing B cells to alter their Ag receptors through
ley et al., 1993). Genotypes of the Tg offspring were determined bythe editing process or progress to the mature B stage
PCR of tail snip genomic DNA. Radiation chimeras were preparedand survive in an anergic state.
as previously described (Hartley et al., 1993). Briefly, recipient mice
Why does editing occur in only a subpopulation of were lethally irradiated with 900 rads from a cesium source and
the B cells in HEL-Ig/bcl-xL → mHEL and triple Tg mice? were immediately infused intravenously through the lateral tail vein
with 2 3 106 BM cells from either HEL-Ig or HEL-Ig/bcl-xL doubleA possible explanation is that while mHEL Tg mice ex-
Tg animals. Mixed chimeras were produced at both the Universitypress a membrane bound form of HEL, they also have
of Minnesota and at Stanford University with comparable results.a significant concentration of soluble HEL in serum (50±
Chimeras were generally analyzed 6±12 weeks after reconstitution.200 ng/ml [Akkaraju et al., 1997]), presumably shed from
All mice were housed in specific pathogen-free conditions.
cell surfaces by protease activity (Brooks et al., 1991).
Given the high Kd of the anti-HEL receptor (10212 M), the Flow Cytometric Analysis
receptors on newly differentiated immature B cells in Spleen and BM cell suspensions were prepared for FACS staining
as described (Fanget al., 1996). Two- and three-color flow cytometrythis system are likely to be simultaneously engaged by
of the cell suspensions was performed on a FACScan or FACScali-both soluble and membrane bound self-Ag, with individ-
bur (Becton-Dickinson) andanalyzed using Cell Quest (Becton-Dick-ual cells exposed to a variable mix of mHEL and sHEL.
inson) software. The following directly conjugated MAbs were
Cells with the strongest degree of cell surface Ig cross- purchased from PharMingen (San Diego, CA): Cychrome or Phy-
linking (mHEL . sHEL) may undergo editing, while cells coerythrin (PE) anti-B220 (RA3±6B2), fluorescein isothiocyanate
with the least amount of cross-linking (sHEL . mHEL) (FITC) anti-IgMa (DS-1), PE anti-IgDa (AMS9.1), FITC anti-CD21 (7G6),
FITC anti-CD43 (S7), FITC anti-CD23 (B3B4), FITC anti-L-selectinmay not receive a sufficient signal to engage either the
(CD62L) (MEL-14), and FITC anti-CD22 (Cy34.1). Directly conjugatedrecombination machinery or the apoptotic death ma-
isotype controls were also purchased from PharMingen. The HELchinery and thus escape with intact, but anergic, recep-
sandwich assay was performed as described (Goodnow et al., 1988).
tors to the periphery. Alternatively, Bcl-xL may inhibit Cells were incubated with 10 mg/ml HEL (Sigma, St. Louis, MO) and
signals from the BCR to the nucleus such as calcium- after washing were stained with biotinylated HyHEL9 MAbs and
induced transcription factors, similar to the mechanism detected with streptavidin-FITC (Caltag, South San Francisco, CA).
recently described for Bcl-2 (Linette et al., 1996). When
PCR and RT±PCRconstitutively overexpressed, Bcl-xL might then reduce
Genomic DNA and cellular mRNA were purified and PCR and RT±the magnitude of mHEL-triggered signals down to the
PCR were performed essentially as described (Schlissel and Balti-
level that normally occurs in anergic B cells binding the more, 1989; Fang et al., 1996). V-Jk1 rearrangements were detected
weaker sHEL Ag. Further studies with these bcl-xL Tg in genomic DNA by PCR using an upstream Vk degenerate primer
mice should prove useful in dissecting the relative roles (Schlissel and Baltimore, 1989) and the following reverse primer
downstream of the Jk1 coding region: 59-CTT TGC CTT GGA GAGof avidity, affinity, and strength of signaling in the pro-
TGC CAG AAT CTT G-39. Products were electrophoresed on 1%cesses of editing and negative selection.
agarose gels, blotted to nitrocellulose, and detected with a radiola-In normal individuals, potentially self-reactive B cells
beled internal oligonucleotide (59-GAG TAA GAT TTT ATA CAT CATcan be detected at low frequencies in peripheral blood
TTT TAG ACA-39). The Jk constant region control PCR was as de-
(Hardy et al., 1987; Klinman and Steinberg, 1987; Piset- scribed (O'Brien et al., 1997).
sky et al., 1990; He et al., 1993), suggesting that the
escape of self-reactive B cells from clonal deletion is In Vitro Assays
ELISAspot assay for the detection of anti-HEL IgMa secreting cellsoccurring at a detectable rate in the normal immune
was performed as previously described (Goodnow et al., 1989). Forsystem. Why might the immune system wish to induce
the in vitro assays, splenic B cells were purified at 48C by magneti-anergy in some autoreactive cells, rather than simply
cally depleting non-B cells with antibodies to Thy-1 (PerSeptive
destroy them in bone marrow? A possible role for such Biosystems, Cambridge, MA) and Mac-1 (Caltag). B cells prepared
anergic B cells would be to recognize and internalize in this manner were greater than 90% B2201. For proliferation
cross-reactive pathogens and then present unique and assays, 5 3 104 B cells were cultured in triplicate in 96-well flat-
bottom microtiter plates at 378C in 5% CO2, in 0.2 mls of 10%foreign peptides to CD41 T cells to initiate protective
fetal calf serum containing RPMI media supplemented with 2 mMimmune responses. Thus, the inclusion of anergic cells
L-glutamine, and 50 mM 2-mercaptoethanol. Anti-HEL IgMa antibod-in the repertoire may serve to broaden the diversity of
ies were detected by ELISA assay from the supernatants of 7 day
B cell receptors available to recognize pathogens, while cultures of triplicate wells. Flow cytometry was performed onparallel
the anergic state of the individual cell (shortened life- cultures performed in 24-well plates (0.5 3 106 cells/ml). LPS
span, reduced ability to compete with normal B cells (Sigma), polyclonal goat-anti-mouse IgM antibodies (Cappel, Dur-
ham, NC), and soluble HEL protein (Sigma) were added at the initia-for entry into lymphoid follicles, impaired proliferative
tion of the cultures.responses, etc. [Goodnow, 1996]) would protect the
host from autoimmune anti-self responses.
In Vivo Adoptive Transfer Experiments
Ovalbumin-specific T cells were obtained from the draining lymph
nodes of B6 mice 12 days following subcutaneous immunizationExperimental Procedures
with 200 mg ovalbumin protein (Pierce, Rockford, IL) in complete
Freund's adjuvant (Sigma). Naive LN T cells were collected fromTransgenic and Chimeric Mice
bcl-xL cell Tg mice (Fang et al., 1996) were backcrossed onto the unimmunized B6 mice. Purified B2201IgMa1 splenocytes (1.1 3 106)
from HEL-Ig/bcl-xL → mHEL radiation chimeras were adoptivelyC57Bl/6J (B6) background for nine generations, and were then bred
with MD4 HEL-Ig Tg mice (Goodnow et al., 1988) to produce HEL- transferred together with 1 3 107 naive or ovalbumin-primed T cells
into sublethally irradiated C57Bl/6J recipients (500 rads) as de-Ig/bcl-xL double Tg animals. KLK4 mHEL Tg (Hartley et al., 1991)
and B6 mice (Jackson Laboratories, Bar Harbor, ME) were used as scribed (Hartley et al., 1993). Recipient mice were then immunized
within 2 hr with 40 mg HEL-ovalbumin whole protein conjugate inBM chimera recipients. Triple Tg mice (HEL-Ig/bcl-xL/mHEL) were
produced by breeding HEL-Ig/bcl-xL double Tgs with mHEL homo- complete Freund's adjuvant. HEL and ovalbumin were chemically
conjugated as described (Jacobs et al., 1993). Serum anti-HEL IgMazygote or heterozygote Tg mice. Bcl-2±22 Tg mice (Strasser et al.,
Immunity
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titers were measured at the designated time points by ELISA from Fang, W., Rivard, J.J., Mueller, D.L., and Behrens, T.W. (1994). Clon-
ing and molecular characterization of mouse bcl-x in B and T lym-eye bleed serum. Animals were sacrificed at 17 days and spleno-
phocytes. J. Immunol. 153, 4388±4398.cytes were analyzed by the anti-HEL ELISAspot assay.
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